These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
49 related items for PubMed ID: 527788
1. [How should one assess activity in Crohn's disease? Argument for a biological and clinical index. A cooperative study of the Research Group on Cryptogenetic Enterocolitis]. André C, Descos L, Cerf M. Gastroenterol Clin Biol; 1979 Nov; 3(11):785-7. PubMed ID: 527788 [No Abstract] [Full Text] [Related]
2. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease. Winterkamp S, Weidenhiller M, Otte P, Stolper J, Schwab D, Hahn EG, Raithel M. Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192 [Abstract] [Full Text] [Related]
3. Evaluation of the Crohn's Disease Activity Index (CDAI) and the Dutch Index for severity and activity of Crohn's disease. An analysis of the data from the European Cooperative Crohn's Disease Study. Goebell H, Wienbeck M, Schomerus H, Malchow H. Med Klin (Munich); 1990 Oct 15; 85(10):573-6. PubMed ID: 2233586 [Abstract] [Full Text] [Related]
4. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Best WR, Becktel JM, Singleton JW, Kern F. Gastroenterology; 1976 Mar 15; 70(3):439-44. PubMed ID: 1248701 [Abstract] [Full Text] [Related]
5. An interesting association between pseudomembranous colitis and Crohn's disease. Behan WM, Peebles-Brown DA. Br J Clin Pract; 1981 Feb 15; 35(2):87-90. PubMed ID: 7259949 [No Abstract] [Full Text] [Related]
8. Correlation between levels of C-reactive protein and clinical activity in Crohn's disease. Karoui S, Ouerdiane S, Serghini M, Jomni T, Kallel L, Fekih M, Boubaker J, Filali A. Dig Liver Dis; 2007 Nov 15; 39(11):1006-10. PubMed ID: 17889628 [Abstract] [Full Text] [Related]
9. [Diagnostic errors in Crohn's granulomatous enterocolitis and their avoidance]. Deltz E, Hantschmann N. Med Welt; 1977 Mar 11; 28(10):478-81. PubMed ID: 859415 [No Abstract] [Full Text] [Related]
11. "Crohn's disease activity index" is inaccurate to detect the post-operative recurrence in Crohn's disease. A GISC study. Gruppo Italiano per lo Studio del Colon e del Retto. Viscido A, Corrao G, Taddei G, Caprilli R. Ital J Gastroenterol Hepatol; 1999 May 11; 31(4):274-9. PubMed ID: 10425569 [Abstract] [Full Text] [Related]
12. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S. Dig Liver Dis; 2004 May 11; 36(5):342-7. PubMed ID: 15191204 [Abstract] [Full Text] [Related]
13. Prospective assessment of Cleveland Global Quality of Life (CGQL) as a novel marker of quality of life and disease activity in Crohn's disease. Kiran RP, Delaney CP, Senagore AJ, O'Brien-Ermlich B, Mascha E, Thornton J, Fazio VW. Am J Gastroenterol; 2003 Aug 11; 98(8):1783-9. PubMed ID: 12907333 [Abstract] [Full Text] [Related]
16. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course. Kim BC, Park S, Han J, Kim JH, Kim TI, Kim WH. Dig Liver Dis; 2007 Jul 11; 39(7):610-6. PubMed ID: 17531556 [Abstract] [Full Text] [Related]
17. Altered subjective appetite parameters in Crohn's disease patients. Bannerman E, Davidson I, Conway C, Culley D, Aldhous MC, Ghosh S. Clin Nutr; 2001 Oct 11; 20(5):399-405. PubMed ID: 11534934 [Abstract] [Full Text] [Related]
18. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease. Jones J, Loftus EV, Panaccione R, Chen LS, Peterson S, McConnell J, Baudhuin L, Hanson K, Feagan BG, Harmsen SW, Zinsmeister AR, Helou E, Sandborn WJ. Clin Gastroenterol Hepatol; 2008 Nov 11; 6(11):1218-24. PubMed ID: 18799360 [Abstract] [Full Text] [Related]